Skip to content

Functional evaluation of neutrophil of patients at high risk for infection treated with monocyte/ neutrophil apheresis

Functional evaluation of neutrophil of patients at high risk for infection treated with monocyte/ neutrophil apheresis - Evaluation trial of SPA-01

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000012245
Enrollment
40
Registered
2013-11-08
Start date
2013-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis, large bowel perforation, esophageal cancer, colorectal cancer

Interventions

monocyte/neutrophil apheresis non monocyte/neutrophil apheresis

Sponsors

Mie University Hospital
Lead Sponsor
Department of Infectious Diseases, Hiroshima University Graduate School of Medicine
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Following patients at high risk for postoperative infection -wound class 2 and over -with infection -poor nutrition or general status -undergo major-invasive surgery

Exclusion criteria

Exclusion criteria: -patients with cardiovascular disease (acute myocardial infarction, ischemic heart disease, or arrhythmia requiring treatment within 6 months of onset) -with or with past histories of cerebral infarction or cerebrovascular disorder including intracerebral hemorrhage -patients with hypotension or systolic blood pressure of 80mmHg and under -pregnant or breast feeding women and women suspected of being pregnant -demented persons -patients with a histories of shock during extracorporeal circulation therapy -patients receiving angiotensin-converting enzyme inhibitors and inappropriate in these drugs withdrawal prior to apheresis -patients judged as inadequate for this study by attending physician

Design outcomes

Primary

MeasureTime frame
Evaluation neutrophil function of patients at high risk for postoperative infection treated with monocyte/neutrophil apheresis

Secondary

MeasureTime frame
Identification of amount of blood apheresis needed for improvement in function of neutrophil

Countries

Japan

Contacts

Public ContactToshimitsu Araki

Mie University Hospital Center of maternal and child health

taraki@clin.medic.mie-u.ac.jp059-232-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026